zofran attorney

  • Date: Dec 11, 2015
  • Category: Legal

Zofran Lawsuit Plaintiffs Learn Of Co-Lead Counsel Appointments

Judge F. Dennis Saylor has appointed three attorneys as co-lead counsel for MDL 2657. Continue reading →

  • Date: Dec 04, 2015
  • Category: Legal

Zofran Lawsuit Plaintiffs Question Doctor’s Ability To Prescribe Drugs Off-Label

As the number of Zofran lawsuits grows, plaintiffs question why doctors aren’t prevented from prescribing drugs off-label. Continue reading →

  • Date: Oct 30, 2015
  • Category: Legal

New Zofran Lawsuit Claims Idaho Child’s Birth Defect Caused By The Drug

The parents of a young boy born in Idaho have filed a lawsuit against GlaxoSmithKline. They allege that the drug Zofran caused their child’s birth defects. Continue reading →

  • Date: Sep 11, 2015
  • Category: Legal

New Zofran Lawsuit Filed In The State Of Louisiana

A new lawsuit has been filed in the state of Louisiana alleging that a child was born with a cleft palate because her mother was prescribed Zofran during the first trimester of her pregnancy. Continue reading →

  • Date: Sep 04, 2015
  • Category: Legal

New Zofran Lawsuit Alleges Cardiac Defect Caused By Mothers Use of Zofran

A new lawsuit filed in the state of Alabama alleges that an infant boy suffers from a rare heart defect known as Hypoplastic Left Heart Syndrome because his mother took Zofran during her pregnancy to treat morning sickness. Continue reading →

  • Date: Aug 28, 2015
  • Category: Legal

New Lawsuit Alleges Zofran Birth Defects Diagnosed In Illinois Child

A new lawsuit filed in Illinois alleges that the birth defect discovered in a young boy was secondary to the use of Zofran by his mother during her pregnancy. Continue reading →

  • Date: May 08, 2015
  • Category: Family

A New Zofran Lawsuit Claims Birth Defects Caused Termination

On April 17, 2015, a woman from Massachusetts filed suit against pharmaceutical giant GlaxoSmithKline. She claims that Zofran, an anti-nausea drug frequently prescribed “off-label” to treat morning sickness, caused her unborn child to develop a severe abdominal birth defect. As a result, plaintiff was forced to terminate her pregnancy. Continue reading →

  • Date: Apr 13, 2015
  • Category: Legal

Zofran Lawsuits Seek Damages For Twelve Birth Defects

GlaxoSmithKline’s Zofran, which is FDA approved to treat severe nausea and vomiting only in cancer patients and those undergoing surgical anesthesia, has also become a leading treatment for morning sickness, despite the fact that its effects during pregnancy have never been adequately studied. Four lawsuits have now been filed, claiming that Zofran has the potential to cause birth defects and that GlaxoSmithKline was aware of the drug’s potential dangers but marketed it to pregnant women’s physicians anyway. In total, plaintiffs allege that GlaxoSmithKline’s medication caused twelve separate birth defects. Continue reading →

  • Date: Apr 08, 2015
  • Category: Family

Four Lawsuits Claim That Child Birth Defects Were Caused By Zofran

Four families have now filed lawsuits against GlaxoSmithKline, alleging that the pharmaceutical giant’s anti-nausea drug Zofran caused their children’s debilitating birth defects. While Zofran is FDA approved to treat nausea and vomiting in patients undergoing cancer treatments and surgical anesthesia, it has never been approved for morning sickness. In their complaints, plaintiffs claim that GlaxoSmithKline not only failed to test Zofran’s effects on fetal development, but may in fact have known of the drug’s significant health risks and failed to warn the public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 17, 2015
  • Category: Legal

Monheit Law Releases A 12 Point Guide To Zofran Birth Defect Lawsuits

In order to better inform the public, a national coalition of distinguished plaintiffs’ attorneys has released a comprehensive guide on litigation surrounding GlaxoSmithKline’s popular anti-nausea drug Zofran. Recent studies have begun to establish a link between Zofran’s active ingredient, Ondansetron, and severe birth defects including cleft palate and congenital heart defects. Now, recently-filed lawsuits (filed under case numbers 1:15-cv-10429 and 2:15-cv-00709PD) claim that GlaxoSmithKline was aware of Zofran’s risks, but unlawfully marketed the drug to obstetricians and gynecologists as a safe treatment for morning sickness. Continue reading →